JP2884104B2 - Anti-mutagenic agent derived from salamander - Google Patents

Anti-mutagenic agent derived from salamander

Info

Publication number
JP2884104B2
JP2884104B2 JP2209624A JP20962490A JP2884104B2 JP 2884104 B2 JP2884104 B2 JP 2884104B2 JP 2209624 A JP2209624 A JP 2209624A JP 20962490 A JP20962490 A JP 20962490A JP 2884104 B2 JP2884104 B2 JP 2884104B2
Authority
JP
Japan
Prior art keywords
extract
mutagenic
water
salamander
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2209624A
Other languages
Japanese (ja)
Other versions
JPH0491030A (en
Inventor
徳久 河合
幸修 西部
義隆 安藤
裕 安藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ichimaru Pharcos Co Ltd
Original Assignee
Ichimaru Pharcos Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ichimaru Pharcos Co Ltd filed Critical Ichimaru Pharcos Co Ltd
Priority to JP2209624A priority Critical patent/JP2884104B2/en
Publication of JPH0491030A publication Critical patent/JPH0491030A/en
Application granted granted Critical
Publication of JP2884104B2 publication Critical patent/JP2884104B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

【発明の詳細な説明】 〔発明の目的〕 本発明は、抗変異原性作用剤:バイオアンチミュータ
ジェンの新規な開発に関する。
DETAILED DESCRIPTION OF THE INVENTION [Object of the Invention] The present invention relates to a novel development of an anti-mutagenic agent: bioantimutagen.

更に詳しくは、その原料起源が、生薬の一つとして知
られ、「日局」にも、収載されているミカン科の植物で
ある、サンショウ(Zanthoxylum piperitum De Candoll
e)又はその他同属植物の成熟した果実から抽出して得
られる、新規なバイオアンチミュータジェンに関する。
More specifically, Zanthoxylum piperitum De Candoll, a citrus plant known as one of the herbal medicines and listed in the Japan Pharmacopoeia,
e) or other novel bioantimutagens obtained by extracting from mature fruits of the same genus plants.

「産業上の利用分野」 本発明により特定されるサンショウ由来の抽出物によ
れば、抗変異原性作用に優れ、効率の良いDNA修復作用
を発揮する。
“Industrial application field” According to the extract derived from salmon specified by the present invention, the extract has excellent anti-mutagenic activity and exhibits an efficient DNA repair activity.

よって、例えば、医薬品、化粧品、食品(健康食品)
の製剤分野に配合して用い、変異原性因子によって誘発
される、遺伝毒性、癌、老化等の抑制、或は、それらの
予防を目的として利用することが出来る。
So, for example, pharmaceuticals, cosmetics, foods (health foods)
It can be used for the purpose of suppressing genotoxicity, cancer, aging, etc. induced by mutagenic factors, or preventing them.

又、動物用医薬品、医薬部外品、あるいは動物用飼料
に添加して利用することも出来る。
It can also be used by adding it to veterinary drugs, quasi-drugs, or animal feed.

「従来の技術」 これまでに、癌や遺伝毒性等が誘発される原因の一つ
として、環境中に存在する種々の変異原性作用因子が、
生体内の遺伝情報に変化をもたらし、これが固定化する
ことで生じるという機構が知られている。
"Conventional technology" As one of the causes of cancer and genotoxicity, various mutagenic agents existing in the environment have been
There is known a mechanism that causes a change in genetic information in a living body, which is caused by immobilization.

すなわち、変異原として知られる、紫外線や、天然物
中の蛋白質の加熱分解物や、芳香族性ニトロ化合物など
の誘発性因子が、DNAに損傷を与え、これが突然変異と
して固定化されることによって、様々な病変が引き起こ
されることが確認されており、それらの病変の抑制、或
は予防について、活発な研究が行われている。
In other words, ultraviolet rays, heat decomposed products of proteins in natural products, and inducible factors such as aromatic nitro compounds, which are known as mutagens, damage DNA and are immobilized as mutations. It has been confirmed that various lesions are caused, and active research is being conducted on the suppression or prevention of those lesions.

その研究の過程において、予防や治療を目的として、
様々な抗変異原性作用物質の存在が確認され、それらの
検索や同定に力が注がれている。
In the course of the research, for the purpose of prevention and treatment,
The existence of various anti-mutagenic agents has been identified, and efforts have been made to search and identify them.

この抗変異原性物質は、変異原性因子に対して、直接
的に働きかけ、変異原性活性を失活化するという性質の
ものと、変異原性作用を受けた細胞に働きかけ、DNAを
修復し、その突然変異作用の発現を抑制する性質をもつ
ものとに大別され、前者をデスミュータジェン、後者を
バイオアンチミュータジェンと提唱され、前者の性質を
有する物質として、例えば、パーオキシダーゼ、カタラ
ーゼといった酵素や、ビタミンC等が確認されており、
後者においては、お茶、野菜類などから抽出される活性
物質が知られている。
This anti-mutagenic substance acts directly on mutagenic factors and inactivates mutagenic activity, and it works on mutagenic cells to repair DNA. And it is roughly classified into those having the property of suppressing the expression of the mutation action, the former is called desmutagen, the latter is proposed as bioantimutagen, and as a substance having the former property, for example, peroxidase, Enzymes such as catalase and vitamin C have been confirmed.
In the latter, active substances extracted from tea, vegetables and the like are known.

「発明が解決しようとする課題」 本発明者らは、有用な抗変異原性作用をもった新たな
物質を、天然産物:植物中に求め、その開発に当ること
を課題となし、鋭意研究を続けてきた。
"Problems to be Solved by the Invention" The present inventors have sought to find new substances having useful antimutagenic activity in natural products: plants and to develop them. Has been continued.

その結果、ミカン科の植物である、サンショウ(Zant
hoxylum piperitum De Candolle)又はその他同属植物
の成熟した果実(以下、単に、サンショウという)から
得られた、水溶性抽出物中に、抗変異原活性と効率の良
いDNA修復作用をもった、バイオアンチミュータジェン
が存在することを見い出した。
As a result, the citrus plant, Zant (Zant
hoxylum piperitum De Candolle) or other fruits of the same genus plant (hereinafter simply referred to as “sansho”), a water-soluble extract with anti-mutagenic activity and efficient DNA repair I found that antimutagen exists.

〔発明の構成〕[Configuration of the invention]

本発明は、ミカン科植物サンショウの果実から得られ
た分子量1万以下の水溶性抽出物を有効成分として含量
するバイオアンチミュータジェンより構成する。
The present invention comprises a bioantimutagen containing, as an active ingredient, a water-soluble extract having a molecular weight of 10,000 or less obtained from the fruit of a fruit of the citrus plant Sansho.

「課題を解決するための手段」 サンショウより、種々の溶媒を用いて抽出を試み、得
られた成分について、抗変異原性活性の有無を確認した
結果、水溶性抽出物中に強い活性を示す物質が存在して
いることが分かった。
"Means for solving the problem" Extraction was performed using various solvents from salamander, and the resulting components were confirmed to have anti-mutagenic activity. As a result, strong activity was found in the water-soluble extract. The indicated material was found to be present.

そこで、本発明者らは、その水溶性抽出物について、
更に詳しく追及していく為、まず、得られた水溶性抽出
物について、様々な工程によって分画を試み、その折々
に分取された物質について、抗変異原性活性を測定し、
その活性度の高いものを絞り込んでいった。
Therefore, the present inventors, regarding the water-soluble extract,
In order to pursue further details, first, the obtained water-soluble extract was subjected to fractionation by various steps, and the anti-mutagenic activity was measured for the substance collected at each time,
We narrowed down those with high activity.

その操作としては、具体的には下記、操作〜のよ
うに行った。
Specifically, the operation was performed as in the following operation.

操作 サンショウより得られた水溶性抽出物を、凍結乾燥し
て、得られた乾燥物に、クロロホルム・酢酸エチルを加
え、良く撹拌した後、遠心分離を行う。尚、ここで得ら
れた有機溶媒層〈クロロホルム・酢酸エチル層〉(以
下、便宜上、A抽出物という)及び、残渣物(以下、便
宜上、B抽出物という)について、活性度を測定した結
果、A抽出物、及びB抽出物の両方とも、活性は認めら
れたが、特に、B抽出物に強い活性を示すことが確認で
きた。
Procedure The water-soluble extract obtained from the salamander is freeze-dried, chloroform / ethyl acetate is added to the obtained dried product, and the mixture is thoroughly stirred and then centrifuged. The organic solvent layer <chloroform / ethyl acetate layer> (hereinafter, referred to as A extract for convenience) and the residue (hereinafter, referred to as B extract for convenience) were measured for activity. Both the A extract and the B extract showed activity, but it was confirmed that the B extract showed particularly strong activity.

操作 そこで、次に、操作で得られたB抽出物に、冷水
(0〜5℃)を加え、良く撹拌し、遠心分離した後、同
様に可溶部〈冷水溶解部〉(以下、便宜上、C抽出物と
いう)及び、残渣物(以下、便宜上、D抽出物という)
について、活性を確認したところ、C抽出物について
は、特に、強い活性を確認した。また、D抽出物にも、
若干の活性があることが確認された。
Operation Therefore, next, cold water (0 to 5 ° C.) was added to the B extract obtained by the operation, and the mixture was thoroughly stirred and centrifuged. Similarly, a soluble portion (cold water dissolving portion) (hereinafter, for convenience, C extract) and residue (hereinafter referred to as D extract for convenience)
The activity of the C extract was confirmed to be particularly strong. In addition, D extract
It was confirmed that there was some activity.

操作 そこで、操作で得られたC抽出物について、それが
如何なる物質であるか、その同定を試みた結果、下記の
如くの、理化学的性質を有する成分であることが、確認
された。
Operation Then, as to the C extract obtained by the operation, an attempt was made to identify what kind of substance it was, and as a result, it was confirmed that the extract was a component having the following physicochemical properties.

〔1〕理化学的性質に関する試験 (1)薄層クロマトグラム試験 試験1. 薄層板:シリカゲル 60 F254 展開溶媒:エタノール/精製水=(9:1) 温度:室温 Rf値:0.33〜0.66 試験2. 薄層板:シリカゲル 60 F254 展開溶媒:メタノール/酢酸=(9:1) 温度:室温 Rf値:0.88 試験3. 薄層板:シリカゲル 60 F254 展開溶媒:クロロホルム/メタノール/精製水=(13:
7:2)混液の下層部 温度:室温 Rf値:0.12 (2)溶剤に対する溶解性試験 水に易溶、メタノール、エタノール、酢酸エチル、ク
ロロホルムに不溶であることが確認された。
[1] Test on physicochemical properties (1) Thin layer chromatogram test Test 1. Thin plate: silica gel 60 F254 Developing solvent: ethanol / purified water = (9: 1) Temperature: room temperature Rf value: 0.33 to 0.66 Test 2 Thin plate: silica gel 60 F254 Developing solvent: methanol / acetic acid = (9: 1) Temperature: room temperature Rf value: 0.88 Test 3. Thin plate: silica gel 60 F254 Developing solvent: chloroform / methanol / purified water = (13:
7: 2) Lower layer of mixed solution Temperature: room temperature Rf value: 0.12 (2) Solubility test in solvent It was confirmed that it was easily soluble in water and insoluble in methanol, ethanol, ethyl acetate and chloroform.

(3)分子量確認試験 分子量1万を分別する限外濾過膜(ザルトリウス社製
セントリザルトI)を通過することによって、1万以
下と確認した。
(3) Molecular weight confirmation test It was confirmed that the molecular weight was 10,000 or less by passing through an ultrafiltration membrane (Centrieult I, manufactured by Sartorius) for separating a molecular weight of 10,000.

(4)呈色試験 エタノールに懸濁し、マグネシウムリボンと塩酸を加
えたとき、紅色を呈したことにより、フラボノールを含
有することを確認した。
(4) Color Test When the suspension was suspended in ethanol and a magnesium ribbon and hydrochloric acid were added, the suspension exhibited a red color, confirming that it contained flavonol.

水に溶解し、5%α−ナフトール・エタノール溶液を
加え、H2SO4を静かに重層すると、界面が赤紫色を呈し
たことより、糖類の存在が確認された。(モリッシュ反
応) 塩化第二鉄試薬により、緑褐色を呈したことにより、
多価フェノールを含有することが確認された。
When dissolved in water, a 5% α-naphthol / ethanol solution was added, and H 2 SO 4 was gently overlaid, the presence of a saccharide was confirmed by the interface exhibiting a purple-red color. (Morish reaction) Due to the appearance of greenish brown by the ferric chloride reagent,
It was confirmed to contain polyhydric phenol.

n−ブタノール中において、塩酸を加えて、加熱する
とき、淡赤色を呈した。
When n-butanol was added with hydrochloric acid and heated, it turned pale red.

(5)赤外吸収スペクトル試験 KBr法による赤外吸収スペクトルは、第1図の如くで
ある。
(5) Infrared absorption spectrum test The infrared absorption spectrum by the KBr method is as shown in FIG.

〔2〕製造法の検討 これまでに試みた分画操作、及び、理化学的性質をも
とに、この抗変異原性活性物質を高濃度に含有する抽出
物を得る方法(溶媒や分画操作など)を、いろいろと検
討した結果、下記に示す製造法によれば、高い活性を有
するところの、目的物質が容易に得られることがわかっ
た。
[2] Examination of the production method The fractionation operation attempted so far and the method of obtaining an extract containing the anti-mutagenic active substance at a high concentration based on the physicochemical properties (solvent and fractionation operation) As a result of various investigations, it has been found that the production method described below can easily obtain a target substance having high activity.

製造法 サンショウをそのまま、或は、粉砕し、室温におい
て、精製水で2〜3日間浸漬した後、濾過により、濾液
を分取する。この際に得られた残渣は、上記の操作に従
って、再度抽出し、濾液を分取し、前に得られた濾液と
混合して、抽出物とする。
Production Method The salamander is crushed or pulverized, immersed in purified water at room temperature for 2 to 3 days, and the filtrate is collected by filtration. The residue obtained at this time is extracted again according to the above operation, the filtrate is separated, and mixed with the previously obtained filtrate to obtain an extract.

次に、この抽出物を凍結乾燥して、得られた乾燥物
を、クロロホルム及び、酢酸エチルで、それぞれ数回洗
浄してから、遠心分離して、残渣物を分取する。更に、
この残渣物に、冷水(0〜5℃)を加え、良く撹拌し
て、遠心分離後、不溶物を除去して、得られた溶液を減
圧乾固し、抽出物を得た。
Next, this extract is freeze-dried, and the obtained dried product is washed several times with chloroform and ethyl acetate, respectively, and then centrifuged to separate the residue. Furthermore,
Cold water (0-5 ° C) was added to the residue, and the mixture was stirred well, centrifuged, and insolubles were removed. The resulting solution was dried under reduced pressure to obtain an extract.

尚、抽出溶媒は、精製水に特定する必要はなく、他に
公知な親水性有機溶媒、例えば、1,3−ブチレングリコ
ール、プロピレングリコール、ポリエチレングリコール
等のポリオール系溶媒、グリセリン、アセトン、メタノ
ール、エタノール等と、水との混液を用いることも出来
る。
Incidentally, the extraction solvent does not need to be specified in purified water, and other known hydrophilic organic solvents, for example, polyol solvents such as 1,3-butylene glycol, propylene glycol and polyethylene glycol, glycerin, acetone, methanol, A mixed solution of ethanol or the like and water can also be used.

〔3〕作用又は効果に関する試験 本発明による抗変異原性作用剤に係る効果の測定に当
っては、モチズキ、カダの方法(Mutation Reseach,vo
l.95、p.457、1982年)に従い、紫外線照射方法、及び
バイオアンチミュータジェンを加えた後、その浸とう時
間について、一部に改良を加えて実施した。
[3] Test for action or effect In measuring the effect of the anti-mutagenic agent according to the present invention, the method of Mochizuki and Kada (Mutation Research,
According to I. 95, p. 457, 1982), the ultraviolet irradiation method and the bioantimutagen were added, and the immersion time was partially improved.

その測定法は、次の通りである。 The measuring method is as follows.

(1)菌株の調製 (a)使用菌株 Escherichia Coli B/r WP2 trpを使用。(1) Preparation of strain (a) Used strain Escherichia Coli B / r WP2 trp was used.

(b)紫外線照射法 1晩、前培養した菌を、100mMリン酸ナトリウム緩衝
液(pH7.0)で3回洗浄し、同緩衝液に懸濁させ、シャ
ーレ(直径90mm)に移す。この際、液層は約4mmとす
る。
(B) Ultraviolet irradiation method The bacteria precultured overnight are washed three times with a 100 mM sodium phosphate buffer (pH 7.0), suspended in the same buffer, and transferred to a petri dish (90 mm in diameter). At this time, the liquid layer is about 4 mm.

次いでこれを撹拌しながら、47.8J/m2相等量の紫外線
を照射した。
Then, while stirring this, 47.8 J / m 2 phase equivalent ultraviolet rays were irradiated.

(2)検体の調製 製造法によって得られた試料(抽出物、抽出)
を、一定量、50%ジメチルスルホキシド(DMSO)水溶液
に溶解させたものを、60μl採取し、滅菌した試験管に
入れ、100mMリン酸ナトリウム緩衝液(500μl)を加
え、調製した。
(2) Sample preparation Sample (extract, extraction) obtained by the manufacturing method
Was dissolved in a 50% aqueous solution of dimethylsulfoxide (DMSO), and 60 μl of the solution was collected, placed in a sterilized test tube, and added with 100 mM sodium phosphate buffer (500 μl) to prepare.

尚、比較検体として、既知抗変異原性物質として知ら
れている、ケイヒアルデヒドを採用した。
As a comparative sample, cinnamaldehyde, which is known as a known anti-mutagenic substance, was used.

(3)測定法 前記(2)の調製液に、前記(1)で得られた菌懸濁
液100μlを加え、37℃、30分間振とうを行い、次に2.5
mlの軟寒天を加えて、最小グルコース寒天培地に広げた
後、37℃で、72時間の培養を行い、育成したコロニーを
もって、突然変異した菌と判定する。
(3) Measurement method 100 μl of the bacterial suspension obtained in the above (1) was added to the prepared solution of the above (2), and the mixture was shaken at 37 ° C. for 30 minutes.
After adding ml of soft agar and spreading on a minimum glucose agar medium, culturing is carried out at 37 ° C. for 72 hours, and the grown colonies are judged as mutated bacteria.

尚、生菌数の判定は、37℃、30分間振とうした後の混
液を、100mMリン酸ナトリウム緩衝液で、50の3剩倍
(1.25×105倍)に希釈して、前培養用液体培地に寒天
を加えて作った培地に広げ、37℃、24時間の培養後のコ
ロニー数を生菌数とした。
The viable cell count was determined by diluting the mixed solution after shaking at 37 ° C. for 30 minutes with 100 mM sodium phosphate buffer to 50 times 3 times (1.25 × 10 5 times) and pre-culture. The liquid medium was spread on a medium prepared by adding agar, and the number of colonies after culturing at 37 ° C. for 24 hours was defined as the viable cell count.

(4)成績結果 サンショウ由来水溶性抽出物の抗変異原性作用につい
て、次表、「第1表」をもって示す。
(4) Results The antimutagenic effect of the water-soluble extract derived from salamander is shown in the following table, “Table 1”.

尚、本発明において得られた、サンショウ由来水溶性
抽出物は、これを系中に添加することによって、明らか
に突然変異率が減少することが確認できた。
In addition, it was confirmed that the addition of the water-soluble extract derived from salmon obtained in the present invention into the system clearly reduced the mutation rate.

〔4〕発明の効果 本発明のサンショウ由来水溶性抽出物は、前記「第1
表」に示した如く、抗変異原性作用剤(バイオアンチミ
ュータジェン)として評価される。
[4] Effects of the invention
It is evaluated as an anti-mutagenic agent (bioantimutagen) as shown in Table.

特に、抽出された活性成分は、紫外線照射によって誘
発されたDNAの変異を、プレート当たり100μg添加する
ことで、53%抑制する作用を有する。又、このことは、
紫外線の照射によって誘発されたDNAの変異を、効率よ
く修復し、正常に戻すためと考えられる。
In particular, the extracted active ingredient has the effect of suppressing DNA mutation induced by ultraviolet irradiation by 53% by adding 100 μg per plate. This also means
It is considered that DNA mutations induced by irradiation with ultraviolet rays are efficiently repaired and returned to normal.

よって、本発明において得られた、サンショウ由来バ
イオアンチミュータジェンは、前述の如く、遺伝毒性、
癌、老化等の抑制、或は予防を目的とし、例えば、医薬
品、化粧品、食品、あるいは醗酵工業、遺伝子工学等を
用いた医薬の開発等への利用が可能である。
Accordingly, the bioantimutagen derived from salmon obtained in the present invention has genotoxicity,
For the purpose of suppressing or preventing cancer, aging, etc., it can be used, for example, in the development of pharmaceuticals, cosmetics, foods, or pharmaceuticals using the fermentation industry, genetic engineering, and the like.

又、医薬品や化粧品あるいは、食品分野への応用に当
っては、必ずしも、その精製物質を用いることを必要と
せず、例えば、前項、操作〜において示された、A
〜D抽出物、又は、製造法で示した、抽出物も用いる
ことが可能である。
In addition, in the application to the field of medicines and cosmetics, or food, it is not always necessary to use the purified substance, for example, A
It is also possible to use the extracts from D to D or the extracts shown in the production method.

すなわち、本発明者らは、新規な抗変異原性作用剤を
天然産物:植物に求め、鋭意研究を重ねた結果、サンシ
ョウから得られた水溶性の抽出物中に、有用な抗変異原
性作用物質が存在することを発見し、これをもとに、そ
の精製化法等を開示した。
That is, the present inventors sought a novel anti-mutagenic agent for a natural product: a plant, and as a result of intensive studies, found that a useful anti-mutagenic agent was contained in a water-soluble extract obtained from salamander. He discovered that a sexually active substance was present, and based on this, disclosed a purification method and the like.

これによって、植物(天然産物)の有効利用を促進す
ることが可能であり、健康増進に、又、その関連産業に
貢献できるものと期待される。
As a result, it is possible to promote the effective use of plants (natural products), which is expected to contribute to health promotion and related industries.

【図面の簡単な説明】[Brief description of the drawings]

第1図は、操作で得られたサンショウ由来水溶性C抽
出物の、赤外線吸収スペクトルである。
FIG. 1 is an infrared absorption spectrum of a water-soluble C extract derived from salamander obtained by the operation.

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】ミカン科植物サンショウの果実から得られ
た分子量1万以下の水溶性抽出物を有効成分として含有
するバイオアンチミュータジェン
1. A bio-antimutagen containing, as an active ingredient, a water-soluble extract having a molecular weight of 10,000 or less obtained from the fruit of the fruit of the citrus plant Sansho.
JP2209624A 1990-08-07 1990-08-07 Anti-mutagenic agent derived from salamander Expired - Lifetime JP2884104B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2209624A JP2884104B2 (en) 1990-08-07 1990-08-07 Anti-mutagenic agent derived from salamander

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2209624A JP2884104B2 (en) 1990-08-07 1990-08-07 Anti-mutagenic agent derived from salamander

Publications (2)

Publication Number Publication Date
JPH0491030A JPH0491030A (en) 1992-03-24
JP2884104B2 true JP2884104B2 (en) 1999-04-19

Family

ID=16575879

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2209624A Expired - Lifetime JP2884104B2 (en) 1990-08-07 1990-08-07 Anti-mutagenic agent derived from salamander

Country Status (1)

Country Link
JP (1) JP2884104B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU784975B2 (en) 2000-10-11 2006-08-10 Sumitomo Chemical Company, Limited DNA-binding protein YB-1-containing collagen accumulation inhibitors
JP2003342184A (en) * 2002-05-31 2003-12-03 Ichimaru Pharcos Co Ltd Hyaluronidase activity inhibitor and cosmetic composition

Also Published As

Publication number Publication date
JPH0491030A (en) 1992-03-24

Similar Documents

Publication Publication Date Title
JPH0222755B2 (en)
Gautam et al. Healing effects of Aegle marmelos (L.) Correa fruit extract on experimental colitis
JP2884104B2 (en) Anti-mutagenic agent derived from salamander
JP5101769B2 (en) Antibiotic antioxidant or preventive agent
JP6974661B2 (en) Cyclic peptide derivative exhibiting water-soluble extract transport action
CN106434787B (en) A kind of corn peel polysaccharide compound and preparation method and medical application
JP2819041B2 (en) Amateur-derived anti-mutagenic agent
JP2009280514A (en) Organic acid peptide-bonded luteolin derivative exhibiting anti-oxidizing action and method for producing the same
JP2003277271A (en) Anticancer drug
JP6273614B2 (en) Hesperetin derivative exhibiting gene repair activating action and method for producing the same
JPH0816062B2 (en) Anti-mutagenic agent derived from fennel
JP3247457B2 (en) Multifunctional protein
JPH02231427A (en) Antimutagenic substance originated from saxifraga stolonifera
JP2001302659A (en) New material isolated from ecklonia cava, method for extraction and purification of the same, method for using the same as antioxidant
JPS638336A (en) External preparation for skin
JPH0686389B2 (en) Anti-UV-induced mutagenic agent derived from Yashabushi fruit
JPH0567610B2 (en)
Affi et al. Comparative Study of Phenolic Compound Antioxidant and Antimicrobial Activities of Fruits Peel and Cladodes from Tunisian Opuntia Stricta. J Altern Complement Integr Med 7: 201
JP2884098B2 (en) Kujin-derived cell activator
JPH04141083A (en) Improver for productivity of microorganism
JP7015775B2 (en) Polyphenol derivative exhibiting gene repair action
JP3150835B2 (en) Process for producing lignan glycosides and lignans
JPH09315992A (en) Suppressor of mutation induced by ultraviolet light
Coolborn et al. HYPTIS SUAVEOLENS L. LEAF EXTRACTS IN TRADITIONAL HEALTH CARE SYSTEMS
JP2022187253A (en) claudin-1 gene expression promoter

Legal Events

Date Code Title Description
S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313532

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313532

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090212

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100212

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100212

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110212

Year of fee payment: 12

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110212

Year of fee payment: 12